This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A predictive model combining multiple ultrasonic parameters could discriminate between different liver diseases in a study published March 19 in Radiology. These findings are important for noninvasive assessment of the MAFLD disease process,” the Liu team wrote. The results have been promising when compared to liver biopsy.
PET, CT, and MRI use for assessing coronary artery disease increased in Medicare patients from 2018 to 2022, while SPECT and stress echocardiography declined over the same period, researchers have reported. Taken together, these findings call for efforts to address barriers impeding wider uptake of PET,” the group wrote.
The guideline emphasizes the need for a multidisciplinary team approach to guide treatment decisions for oligometastatic disease, a description for cancer that reaches a state in which the patient has a small number of metastases in addition to a primary tumor. The guideline is published in Practical Radiation Oncology.
and Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today provided additional information regarding a March 2022 licensing and collaboration agreement between Philochem and Blue Earth Diagnostics.
“The significantly higher lesion-based sensitivity in unsuspected metastases implies a future role of F-18 FAPI PET/CT in evaluation of metastatic disease burden,” the team wrote. The retrospective analysis included data collected in 2022 and 2023 from 38 women with initial clinical stage IIB-IIIC breast cancer. for F-18 FDG.
Organizing pneumonia can hide underlying lung cancers in up to 10% of cases, and repeat imaging in the form of PET/CT -- and additional biopsy -- should be considered in patients with high clinical suspicion of malignancy, researchers have reported. Kim discussed a case that demonstrated how additional biopsy proved necessary.
While care must be individualized, for patients with unknown or unestablished coronary artery disease, the transition to a 'CT first' strategy should be a high priority for cardiovascular care providers," he said. Most study participants were male and white.
In a clinical trial, researchers in Xiamen, China, compared the two approaches for detecting primary and metastatic tumors in patients with confirmed gastric, liver, or pancreatic cancer. Among them, 69 patients underwent PET/CT for initial staging and 43 for the detection of disease recurrence.
A contrast-enhanced ultrasound (CEUS)-based radiomics model could help accurately diagnose breast cancer, suggest findings published November 26 in Clinical Breast Cancer. The researchers enrolled 333 women with breast lesions between 2022 and 2024. They sought to validate the model for improved breast tumor classification.
Health Sci Rep 2022. PMID: 35387313 Clinical Question: Do prehospital antibiotics impact 28 day mortality, length of stay in the hospital and ICU length of stay for patients triggering sepsis compared to usual care (No prehospital antibiotics)? Health Sci Rep 2022. Paper: Varney J et al. to 0.97; p = 0.02 to 2.07; p = 0.91
The study results may suggest ways women transitioning through menopause can be supported as their risk of cerebrovascular disease rises, wrote a team led by Wei Guo, PhD, of the Second Affiliated Hospital of Shandong First Medical University in Taian, China. The study also included 63 men (mean age, 52).
milla1cf Thu, 07/06/2023 - 22:19 July 7, 2023 — Bayer , a global leader in radiology, has initiated the Phase III clinical development program called QUANTI , aiming to evaluate the safety and efficacy of gadoquatrane, an investigational extracellular macrocyclic gadolinium-based contrast agent (GBCA) for use in magnetic resonance imaging ( MRI ).
“AI-driven MRI analysis opens the possibility of accessing previously unavailable clinically-relevant information to reinforce radiology workflows, especially in the context of neurological disorders.” Radiologists and Artificial Intelligence on clinically relevant metrics for detecting activity in Multiple-Sclerosis patients.
FAPI-PET either confirmed or ruled out the disease in all cases, the group found. CT and F-18 FDG-PET are considered clinical gold standards for lung cancer imaging, yet several subtypes of lung cancer, especially the lepidic subtype, are frequently negative on these scans. Access to the full study is available here.
Noninvasive tests can be used to screen patients with chronic liver disease for advanced liver fibrosis. Chen and colleagues constructed sequential clinical algorithms that include an ultrasound deep-learning model. However, the researchers noted that the use of single tests may not be enough to provide an accurate diagnosis.
Recent FDA approvals of new PET radiotracers and therapeutic approaches for high-prevalence diseases, such as prostate cancer and Alzheimer's Disease, emphasize the need for reliable and comprehensive imaging solutions throughout the patient care journey. Feb 3, 2022. Accessed Jun 1, 2022. iii] “Cancer.”
With this grant, our multidisciplinary team aims to improve the medical-imaging process for clinical staff and patients,” said project leader Shuo Li, an associate professor at the university’s Case School of Engineering (CSE). Their goal: a safer, quicker and cheaper process using non-contrast images only.
Some countries support population-wide breast cancer screening programs and track the initial method of detection, whether screening mammography or clinical examination. "[These] disagreements have produced conflicting recommendations that confuse patients and providers and miss opportunities to save lives," it wrote.
We believe this technology could become very important in the clinical workflow of patients with neurological and psychiatric disorders.” While neuromelanin was first described in the 19 th century, researchers have elucidated its possible role as a biomarker for neurological disorders such as Parkinson’s disease in the last two decades.
He noted that in 2019, the European Society of Cardiology issued updated guidelines for diagnostic imaging of coronary artery disease (CAD), recommending noninvasive imaging (i.e., years of follow-up compared with CT imaging (2.1% vs. 3%) and major procedure-related complications during initial management (0.5%
Most Influential Radiology Researcher Erik Middlebrooks, MD, Mayo Clinic, Jacksonville, FL Erik Middlebrooks, MD. One of this year's nominations for Most Influential Radiology Researcher is Erik Middlebrooks, MD, of the Mayo Clinic in Jacksonville, FL. But we're still just scratching the surface."
A PET radiotracer that detects clear-cell renal cell carcinoma proved safe and effective in a clinical trial conducted at 36 research hospitals across nine countries, according to a study published September 10 in the Lancet Oncology. Between August 2019 and July 2022, the group enrolled 284 participants.
The results also follow those of the PICTURE clinical trial published in Investigative Radiology in May, 2023, which found the non-inferior quality of morphologic assessment of lesions of the brain and spine with VUEWAY compared with Gadavist. FDA, resulting in Priority Review and subsequent approval in 2022. mmol/kg). [i]
“Disparities in breast cancer mortality may be mitigated by increasing access to high-quality screening and treatment, especially among Black and Native American women, and increasing diversity in clinical trials,” Giaquinto told AuntMinnie.com. The overall breast cancer death rate continuously declined between 1989 and 2022 by 44%.
Emily Martin, PhD, of the University of Tennessee Medical Center in Knoxville, discussed her group’s latest research on the investigational approach, with repeat scans more than two years after baseline showing changes in cardiac and extracardiac amyloid load associated with the disease.
"Some adverse events [noted] in this study were not mentioned in the package inserts, which need more attention and research to ensure the clinical safety," the group explained. Food and Drug Administration (FDA) approved the first GBCA in 1998, and ever since, this class of drugs has been used with MRI to diagnose disease.
The statement , published online in the Journal of Vascular and Interventional Radiology , is a companion to the 2022 statement on the treatment of acute iliofemoral deep vein thrombosis. For both studies, success will depend on whether providers make it a priority to refer patients to study sites,” he said. “It
milla1cf Mon, 11/20/2023 - 12:49 November 20, 2023 — The American Society for Radiation Oncology (ASTRO) issued a clinical guideline on partial breast irradiation for patients with early-stage invasive breast cancer or ductal carcinoma in situ ( DCIS ).
With the 510(k) approval we expand our ability to help pathology laboratories transform to fully digital workflows, saving time and easing the burden on pathologists and patients,” said Martijn Hartjes, Clinical Informatics Business Leader at Philips. “We Mod Pathol. 2020 Oct;33(10):2058-2066. doi: 10.1038/s41379-020-0551-y. Epub 2020 May 11.
Conversely, FAPI radiotracers such as gallium-68 (Ga-68) FAPI have been developed that bind to fibroblast cells in the supportive tissue of tumors, and these PET tracers have shown significant promise for detecting disease in previous studies. PET/CT and MR images of a 72-year-old woman. (A) but presented no evidence for primary tumor.
MRI is the imaging gold standard for diagnosis, yet identifying the disease using this method remains challenging, the researchers wrote. In our outpatient clinic follow-up (2 to 2.5 years depending on the patient case), all three patients remained stable without new disease relapses,” they noted.
milla1cf Wed, 09/27/2023 - 15:07 September 27, 2023 — The American Society for Radiation Oncology ( ASTRO ) announced the three winning research proposals for the 2022 ASTRO-Myovant Sciences (now known as Sumitomo Pharma)-Pfizer Alliance New Combination (Relugolix-Radiation) Therapy Challenge.
Middlebrooks, MD, Mayo Clinic, Jacksonville, FL Erik H. Middlebrooks, MD, of the Mayo Clinic in Jacksonville, FL. Importantly, we are gaining deeper insights into disease processes themselves, which enhances our ability to diagnose and potentially treat conditions that were previously beyond our reach." Middlebrooks, MD.
Postoperative Assessment 52 yo with post-traumatic degenerative joint disease of the ankle. His clinical interests include ankle arthritis, neuropathic disease, forefoot reconstruction, and deformity. (1) 2022 Mar;27(1):13-36. Epub 2022 Jan 31. 1) Richter M, de Cesar Netto C, Lintz F, Barg A, Burssens A, Ellis S.
Exciting presentations will cover a generative AI model that shows potential for making surgical planning for total hip arthroplasty (THA) more efficient and a deep-learning model developed to identify individuals at high risk of chronic obstructive pulmonary disease (COPD). 1:10 p.m. | 2:00 p.m. | 3:20 p.m. | 8:40 a.m. | 9:20 a.m. |
The ability to determine the extent and location of recurrent prostate cancer to inform appropriate clinical management for these men is key for physicians and their patients, because up to 50% of patients who undergo radiation therapy will develop local or distant recurrences within 10 years,” said Brian T. 2022; 40 (6_suppl):9-9.
Food and Drug Administration in 2022, 177Lu-PSMA is an effective treatment for metastatic castration-resistant prostate cancer. Study participants included 125 men who were treated in a clinical program with six weekly doses of 177Lu-PSMA. Approved by the U.S. The men were imaged with 177Lu-SPECT/CT after each dose. Patients at St.
Background: Point-of-care ultrasound (PoCUS) is a valuable clinical tool in the assessment of acute dyspnea. Thus, PoCUS is an important facilitator that can narrow differential diagnoses and guide treatment plans with better predictive value than traditional clinical practice [6]. Article: Arvig MD, Lassen AT, Gæde PH, et al.
Our heightened emphasis on the North American marketplace solidifies our commitment to making a meaningful impact in the fight against this deadly disease and underscores our dedication to advancing healthcare through innovation, providing a transformative solution enhancing the early detection of cancer and ultimately improving patient outcomes.”
These capabilities will help them develop and deliver products with the potential to improve care for even more patients with serious disease. “In In September 2022, NorthStar and IBA signed a new agreement for two additional Rhodotron TT300 HE electron beam accelerators, and associated beamlines, from IBA for the production of Mo-99.
Creators of groundbreaking lung imaging technologies, 4DMedical reports that it aims to revolutionize respiratory imaging and ventilation for improved lung disease detection and management. The statement further noted that core to both companies is a desire to improve the way lung disease is detected and subsequently managed.
CVC vs PIV The critically ill patient is often associated with pathology that makes IV access difficult such as shock state, hypovolemia, obesity, IV drug abuse, end-stage renal disease, cardiac arrest, as well as other conditions. Clinical Management of Intraosseous Access in Adults in Critical Situations for Health Professionals.
Clinical Question: Does simultaneously performing the modified valsalva maneuver and administering intravenous adenosine, compared to either treatment alone, have greater success in achieving normal sinus rhythm in patients presenting to the ED with PSVT? Most secondary outcomes were disease-oriented with an unclear clinical significance.
radiology portfolio, expanding the range of cost-effective contrast agent options available to hospitals and clinics," said John Ducker , president and CEO of Fresenius Kabi USA. To assess the presence and extent of malignant breast disease in adult patients.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content